113: ZNF-X conferred increased cell proliferation and resistance to the pro-apoptotic action of paclitaxel in breast cancer cells
Aurélie Thollet(Institut du Thorax), Pascale A. Cohen(Lyon 1 Université), Léa Payen(Université Claude Bernard Lyon 1), Sandra E. Ghayad(Inserm), Sabrina Ben Larbi(Lyon 1 Université), Julie A. Vendrell(Inserm), Marie Villedieu(Cancers et Préventions)
Cited by 0
Related Papers
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
|Endocrine Related Cancer|2006|239
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
|European Journal of Cancer|2021|174
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
|Recent Patents on Anti-Cancer Drug Discovery|2009|162